约印15亿医疗大健康产业基金顺利落地：政企携手，为医疗产业创新注入强劲动能

Core Insights - The establishment of the "Yuyin New Source (Chengdu) Equity Investment Partnership" marks a significant milestone for Yuyin Medical Fund, with a total scale of 1.5 billion RMB [1] - The fund has attracted seven top state-owned and national enterprises from key economic regions, showcasing a collaborative model of "state-owned capital + professional investment institutions" to empower medical innovation [1][8] Investment Methodology - Yuyin Medical Fund has developed a comprehensive investment logic of "investing accurately, supporting well, and exiting smoothly," which is the foundation for deep cooperation with industry partners and invested companies [2] - The fund focuses on three core dimensions: clinical needs, technological barriers, and industry chain compatibility, ensuring the selection of high-quality projects with long-term value [2] Support for Invested Companies - Yuyin Medical Fund acts as a "growth partner," providing full-cycle empowerment to entrepreneurs, particularly in areas like team building, strategic development, and addressing common industry challenges [3] - The fund has successfully facilitated 37 projects to the next round of financing and has seen two companies complete mergers and acquisitions, enhancing its reputation among state-owned limited partners [3] Collaborative Ecosystem - The collaboration with seven state-owned limited partners is aimed at creating a "national capital resource + enterprise innovation" ecosystem, promoting the development of the regional medical industry [7][8] - The fund will focus on precision medicine and high-end medical devices, targeting companies with core patents and those capable of international market expansion [7] Strategic Opportunities - The medical health industry is currently experiencing a strategic opportunity period due to overlapping policy support and technological breakthroughs, with Yuyin Medical Fund's collaboration with state-owned institutions enhancing the potential for medical innovation [8]